HARRY H. SLATCH M.D.
Prescription History 1194875310
Urology in Glens Falls, NY
Medicare Part D Prescription History
Explore the verified Medicare Part D prescription history, volume metrics, and calculated drug costs for HARRY H. SLATCH M.D., an active Urology specialist practicing in Glens Falls, NY. Our medical registry currently tracks 15 unique pharmaceutical formulations prescribed by this provider, representing an estimated volume of 1,495 documented patient claims. Among these therapy options, the most frequently utilized medication is Tamsulosin Hcl, which accounts for 486 claims alone. Use the table below to sort by claims, cost, or utilization compared with the state average; select any medication for its full profile.
| Medication | Prescriptions (2024)Rx (2024) | Avg Cost per FillCost / Fill | Vs. Other NY PrescribersVs. NY Avg |
|---|---|---|---|
| Tamsulosin Hcl | 486 | $13.65▼ below NY avg | ▲ More than typical |
About Tamsulosin Hcl: Tamsulosin is used by men to treat the symptoms of an enlarged prostate (benign prostatic hyperplasia-BPH). Show more ▾ It does not shrink the prostate, but it works by relaxing the muscles in the prostate and the bladder. This helps to relieve symptoms of BPH such as difficulty in beginning the flow of urine, weak stream, and the need to urinate often or urgently (including during the middle of the night). Tamsulosin belongs to a class of drugs known as alpha blockers. Do not use this medication to treat high blood pressure. A sulfonamide derivative and adrenergic alpha-1 receptor antagonist that is used to relieve symptoms of urinary obstruction caused by BENIGN PROSTATIC HYPERPLASIA. In 2024, this provider wrote 486 Medicare prescriptions for Tamsulosin Hcl, about 5 times the volume of the typical New York prescriber of this medication (97.4). Medicare paid an average of $13.65 per fill, versus $14.09 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average NY prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the NY average for this medication. 1,175.8 30-Day Fills standardized to 30-day supplies 34,918 Days of Medication total across all patients in 2024 | |||
| Finasteride | 395 | $14.06 | ▲ More than typical |
About Finasteride: Finasteride is used to shrink an enlarged prostate (benign prostatic hyperplasia or BPH) in adult men. Show more ▾ It may be used alone or taken in combination with other medications to reduce symptoms of BPH and may also reduce the need for surgery. Finasteride may improve symptoms of BPH and provide benefits such as decreased urge to urinate, better urine flow with less straining, less of a feeling that the bladder is not completely emptied, and decreased nighttime urination. This medication works by decreasing the amount of a natural body hormone (DHT) that causes growth of the prostate. Finasteride is not approved for prevention of prostate cancer. It may slightly increase the risk of developing a very serious form of prostate cancer. Talk to your doctor about the benefits and risks. Women and children should not use this medication. An orally active 3-OXO-5-ALPHA-STEROID 4-DEHYDROGENASE inhibitor. It is used as a surgical alternative for treatment of benign PROSTATIC HYPERPLASIA. In 2024, this provider wrote 395 Medicare prescriptions for Finasteride, about 6.1 times the volume of the typical New York prescriber of this medication (64.4). Medicare paid an average of $14.06 per fill, versus $11.69 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average NY prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 1,101.7 30-Day Fills standardized to 30-day supplies 33,052 Days of Medication total across all patients in 2024 | |||
| MyrbetriqMirabegron | 139 | $631.14 | ▲ More than typical |
About Myrbetriq: This medication is used to treat certain bladder problems (overactive bladder, neurogenic detrusor overactivity). Show more ▾ Overactive bladder is a problem with how your bladder stores urine. Neurogenic detrusor overactivity is a bladder control condition caused by brain, spinal cord, or nerve problems. Symptoms of these conditions may include frequent urination, strong sudden urges to urinate that are hard to control, or involuntary loss of urine (incontinence). Mirabegron works by relaxing a certain bladder muscle (detrusor), which helps the bladder hold more urine and lessens symptoms of overactive bladder and neurogenic detrusor overactivity. A beta3-adrenergic receptor agonist. In 2024, this provider wrote 139 Medicare prescriptions for Myrbetriq, about 2.7 times the volume of the typical New York prescriber of this medication (51.1). Medicare paid an average of $631.14 per fill, versus $630.56 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average NY prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 197 30-Day Fills standardized to 30-day supplies 5,883 Days of Medication total across all patients in 2024 | |||
| Dutasteride | 90 | $27.55 | ▲ More than typical |
About Dutasteride: This medication is used in men to treat the symptoms of an enlarged prostate (benign prostatic hyperplasia-BPH). Show more ▾ It works by reducing the size of the enlarged prostate. This helps to relieve symptoms of BPH such as difficulty in beginning the flow of urine, weak stream, and the need to urinate often or urgently (including during the middle of the night). It may also reduce the need for surgery to treat BPH. Dutasteride is not approved for prevention of prostate cancer. It may slightly increase the risk of developing a very serious form of prostate cancer. Talk to your doctor about the benefits and risks. This medication should not be used by women or children. A 5-ALPHA-REDUCTASE INHIBITOR that is reported to inhibit both type-1 and type2 isoforms of the enzyme and is used to treat BENIGN PROSTATIC HYPERPLASIA. In 2024, this provider wrote 90 Medicare prescriptions for Dutasteride, about 2.1 times the volume of the typical New York prescriber of this medication (42.3). Medicare paid an average of $27.55 per fill, versus $26.33 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average NY prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 239.1 30-Day Fills standardized to 30-day supplies 7,121 Days of Medication total across all patients in 2024 | |||
| Alfuzosin Hcl ErAlfuzosin Hcl | 60 | $23.83 | ≈ Typical |
About Alfuzosin Hcl Er: Alfuzosin is used by men to treat the symptoms of an enlarged prostate (benign prostatic hyperplasia-BPH). Show more ▾ It does not shrink the prostate, but it works by relaxing the muscles in the prostate and the bladder. This helps to relieve symptoms of BPH such as difficulty in beginning the flow of urine, weak stream, and the need to urinate often or urgently (including during the middle of the night). Alfuzosin belongs to a class of drugs known as alpha blockers. Do not use this medication to treat high blood pressure. In 2024, this provider wrote 60 Medicare prescriptions for Alfuzosin Hcl Er, about the same volume as the typical New York prescriber of this medication (57.2). Medicare paid an average of $23.83 per fill, versus $19.68 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average NY prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 176 30-Day Fills standardized to 30-day supplies 5,280 Days of Medication total across all patients in 2024 | |||
| Tolterodine Tartrate ErTolterodine Tartrate | 60 | $95.49 | ▲ More than typical |
About Tolterodine Tartrate Er: This medication is used to treat an overactive bladder. Show more ▾ By relaxing the muscles in the bladder, tolterodine improves your ability to control your urination. It helps to reduce leaking of urine, feelings of needing to urinate right away, and frequent trips to the bathroom. This medication belongs to the class of drugs known as antispasmodics. An ANTIMUSCARINIC AGENT selective for the MUSCARINIC RECEPTORS of the BLADDER that is used in the treatment of URINARY INCONTINENCE and URINARY URGE INCONTINENCE. In 2024, this provider wrote 60 Medicare prescriptions for Tolterodine Tartrate Er, about 2.5 times the volume of the typical New York prescriber of this medication (23.5). Medicare paid an average of $95.49 per fill, versus $86.44 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average NY prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 102 30-Day Fills standardized to 30-day supplies 3,060 Days of Medication total across all patients in 2024 | |||
| Solifenacin Succinate | 53 | $57.36 | ▲ More than typical |
About Solifenacin Succinate: Solifenacin is used to treat an overactive bladder. Show more ▾ By relaxing the muscles in the bladder, solifenacin improves your ability to control your urination. It helps to reduce leaking of urine, feelings of needing to urinate right away, and frequent trips to the bathroom. This medication belongs to the class of drugs known as antispasmodics. A quinuclidine and tetrahydroisoquinoline derivative and selective M3 MUSCARINIC ANTAGONIST. It is used as a UROLOGIC AGENT in the treatment of URINARY INCONTINENCE. In 2024, this provider wrote 53 Medicare prescriptions for Solifenacin Succinate, about 1.4 times the volume of the typical New York prescriber of this medication (37.3). Medicare paid an average of $57.36 per fill, versus $53.46 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average NY prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 93 30-Day Fills standardized to 30-day supplies 2,790 Days of Medication total across all patients in 2024 | |||
| Ciprofloxacin Hcl | 50 | $4.97▼ below NY avg | ▲ More than typical |
About Ciprofloxacin Hcl: This medication is used to treat a variety of bacterial infections. Show more ▾ Ciprofloxacin belongs to a class of drugs called quinolone antibiotics. It works by stopping the growth of bacteria. This antibiotic treats only bacterial infections. It will not work for virus infections (such as common cold, flu). Using any antibiotic when it is not needed can cause it to not work for future infections. A broad-spectrum antimicrobial carboxyfluoroquinoline. In 2024, this provider wrote 50 Medicare prescriptions for Ciprofloxacin Hcl, about 1.6 times the volume of the typical New York prescriber of this medication (31.0). Medicare paid an average of $4.97 per fill, versus $6.21 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average NY prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the NY average for this medication. 50 30-Day Fills standardized to 30-day supplies 342 Days of Medication total across all patients in 2024 | |||
| Silodosin | 46 | $97.38 | ≈ Typical |
About Silodosin: Silodosin is used by men to treat the symptoms of an enlarged prostate (benign prostatic hyperplasia-BPH). Show more ▾ It does not shrink the prostate, but it works by relaxing the muscles in the prostate and the bladder. This helps to relieve symptoms of BPH such as difficulty in beginning the flow of urine, weak stream, and the need to urinate often or urgently (including during the middle of the night). Silodosin belongs to a class of drugs known as alpha blockers. Do not use this medication to treat high blood pressure. An alpha(1a)-adrenoceptor-selective antagonist. In 2024, this provider wrote 46 Medicare prescriptions for Silodosin, about the same volume as the typical New York prescriber of this medication (42.2). Medicare paid an average of $97.38 per fill, versus $86.78 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average NY prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 105.3 30-Day Fills standardized to 30-day supplies 3,160 Days of Medication total across all patients in 2024 | |||
| NitrofurantoinNitrofurantoin Macrocrystal | 28 | $33.03 | ≈ Typical |
About Nitrofurantoin: This medication is used to treat or prevent certain urinary tract infections. Show more ▾ This medication is an antibiotic that works by stopping the growth of bacteria. It will not work for viral infections (such as common cold, flu). Unnecessary use or overuse of any antibiotic can lead to its decreased effectiveness. Nitrofurantoin should not be used by children less than one month of age due to the risk of a certain blood problem (hemolytic anemia). A urinary anti-infective agent effective against most gram-positive and gram-negative organisms. Although sulfonamides and antibiotics are usually the agents of choice for urinary tract infections, nitrofurantoin is widely used for prophylaxis and long-term suppression. In 2024, this provider wrote 28 Medicare prescriptions for Nitrofurantoin, about the same volume as the typical New York prescriber of this medication (26.9). Medicare paid an average of $33.03 per fill, versus $28.72 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average NY prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 41.6 30-Day Fills standardized to 30-day supplies 1,249 Days of Medication total across all patients in 2024 | |||
| Tadalafil | 24 | $95.96▼ below NY avg | ▼ Less than typical |
About Tadalafil: Tadalafil is used to treat male sexual function problems (impotence or erectile dysfunction-ED). Show more ▾ In combination with sexual stimulation, tadalafil works by increasing blood flow to the penis to help a man get and keep an erection. Tadalafil is also used to treat the symptoms of an enlarged prostate (benign prostatic hyperplasia-BPH). It helps to relieve symptoms of BPH such as difficulty in beginning the flow of urine, weak stream, and the need to urinate often or urgently (including during the middle of the night). Tadalafil is thought to work by relaxing the smooth muscle in the prostate and bladder. This drug does not protect against sexually transmitted diseases (such as HIV, hepatitis B, gonorrhea, syphilis). Practice "safe sex" such as using latex condoms. Consult your doctor or pharmacist for more details. A carboline derivative and PHOSPHODIESTERASE 5 INHIBITOR that is used primarily to treat ERECTILE DYSFUNCTION; BENIGN PROSTATIC HYPERPLASIA and PRIMARY PULMONARY HYPERTENSION. In 2024, this provider wrote 24 Medicare prescriptions for Tadalafil, about 72% of the volume of the typical New York prescriber of this medication (33.2). Medicare paid an average of $95.96 per fill, versus $427.24 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average NY prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the NY average for this medication. 38 30-Day Fills standardized to 30-day supplies 1,140 Days of Medication total across all patients in 2024 | |||
| Oxybutynin Chloride ErOxybutynin Chloride | 21 | $36.05 | ▼ Less than typical |
About Oxybutynin Chloride Er: This is a long-acting form of oxybutynin that is used to treat overactive bladder and urinary conditions. Show more ▾ It relaxes the muscles in the bladder to help decrease problems of urgency and frequent urination. Oxybutynin belongs to a class of drugs known as antispasmodics. This medication is also used to treat children 6 years of age and older who have an overactive bladder due to certain nerve disorders (such as spina bifida). In 2024, this provider wrote 21 Medicare prescriptions for Oxybutynin Chloride Er, about half the volume of the typical New York prescriber of this medication (36.1). Medicare paid an average of $36.05 per fill, versus $20.43 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average NY prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 41 30-Day Fills standardized to 30-day supplies 1,220 Days of Medication total across all patients in 2024 | |||
| Alprazolam | 16 | $2.43▼ below NY avg | ▼ Less than typical |
About Alprazolam: Alprazolam is used to treat anxiety and panic disorders. Show more ▾ It belongs to a class of medications called benzodiazepines which act on the brain and nerves (central nervous system) to produce a calming effect. It works by enhancing the effects of a certain natural chemical in the body (GABA). A triazolobenzodiazepine compound with antianxiety and sedative-hypnotic actions, that is efficacious in the treatment of PANIC DISORDERS, with or without AGORAPHOBIA, and in generalized ANXIETY DISORDERS. (From AMA Drug Evaluations Annual, 1994, p238) In 2024, this provider wrote 16 Medicare prescriptions for Alprazolam, about a third of the volume of the typical New York prescriber of this medication (55.8). Medicare paid an average of $2.43 per fill, versus $6.31 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average NY prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the NY average for this medication. 16 30-Day Fills standardized to 30-day supplies 16 Days of Medication total across all patients in 2024 | |||
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 16 | $19.09 | ▼ Less than typical |
About Nitrofurantoin Mono-Macro: This medication is an antibiotic used to treat bladder infections (acute cystitis). Show more ▾ It works by stopping the growth of bacteria. This antibiotic treats only bacterial infections. It will not work for viral infections (such as common cold, flu). Using any antibiotic when it is not needed can cause it to not work for future infections. This medication should not be used in infants younger than 1 month old (see also Precautions section). This drug should not be used to treat infections outside the bladder (including kidney infections such as pyelonephritis or perinephric abscesses). In 2024, this provider wrote 16 Medicare prescriptions for Nitrofurantoin Mono-Macro, about 63% of the volume of the typical New York prescriber of this medication (25.5). Medicare paid an average of $19.09 per fill, versus $13.08 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average NY prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 16 30-Day Fills standardized to 30-day supplies 208 Days of Medication total across all patients in 2024 | |||
| GemtesaVibegron | 11 | $878.60 | ▼ Less than typical |
About Gemtesa: This medication is used to treat overactive bladder. Show more ▾ Overactive bladder is a problem with how your bladder stores urine that causes a sudden urge to urinate. The urge may be hard to control, and overactive bladder symptoms may include frequent urination, strong sudden urges to urinate, or involuntary loss of urine (incontinence). Vibegron works by relaxing a certain bladder muscle (detrusor), which helps the bladder hold more urine and lessens symptoms of overactive bladder. A beta3 adrenergic receptor agonist. In 2024, this provider wrote 11 Medicare prescriptions for Gemtesa, about 15% of the volume of the typical New York prescriber of this medication (74.8). Medicare paid an average of $878.60 per fill, versus $684.47 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average NY prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 19 30-Day Fills standardized to 30-day supplies 571 Days of Medication total across all patients in 2024 | |||
About this data. The prescription history for HARRY H. SLATCH M.D. is compiled from the Centers for Medicare & Medicaid Services (CMS) Medicare Part D Prescriber Public Use File for calendar year 2024, the most recent federal release. Figures cover prescriptions filled for Medicare Part D beneficiaries only; prescriptions under private insurance, Medicaid, or self-pay plans are not included. Because prescribing decisions are generally consistent across coverage types, this record offers a useful view of the overall Urology prescribing approach at this Glens Falls, NY practice.
Reading the costs. Drug costs are gross amounts paid to pharmacies under Part D, including both plan and beneficiary payments. They are not the price a patient pays at the pharmacy counter. Medications with fewer than 11 claims are excluded from the federal source data, and state comparisons use the average among NY prescribers of the same medication and form, shown only when at least five prescribers contribute. Always confirm current medications and costs directly with the provider and your plan.
About the medication summaries. Drug use descriptions come from the CMS Medicare Part D Drug Spending Dashboard (2024), and substance definitions from Medical Subject Headings (MeSH) 2026, U.S. National Library of Medicine. They are summaries that do not contain all possible information about a medication and are not individual medical advice. Ask a health care professional about any medication and your specific health needs.
